Published in BMJ on July 29, 2010
Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37
Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ (2015) 4.29
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med (2015) 2.88
Clinical practice. Calcium supplements and fracture prevention. N Engl J Med (2013) 2.78
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71
Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause (2014) 2.61
A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care (2011) 2.60
Calcium intake and risk of fracture: systematic review. BMJ (2015) 2.60
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials (2011) 2.59
Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr (2011) 2.44
The calcium scare--what would Austin Bradford Hill have thought? Osteoporos Int (2011) 2.35
Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative. J Am Geriatr Soc (2012) 2.30
Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr (2011) 2.21
Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ (2013) 2.17
Validation of a short questionnaire for estimating dietary calcium intakes. Osteoporos Int (2014) 2.06
Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care (2013) 1.99
Myocardial infarction risk among patients with fractures receiving bisphosphonates. Mayo Clin Proc (2014) 1.98
Cardiovascular effects of calcium supplementation. Osteoporos Int (2011) 1.96
Recommendations for preventing fracture in long-term care. CMAJ (2015) 1.62
Dietary supplements and cancer prevention: balancing potential benefits against proven harms. J Natl Cancer Inst (2012) 1.60
Treating osteoporosis. Aust Prescr (2016) 1.59
Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ (2011) 1.53
Colorectal cancer screening and prevention in women. Dig Dis Sci (2015) 1.46
Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. J Bone Miner Res (2013) 1.44
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
Calcium supplements and cardiovascular risk in the Women's Health Initiative. Osteoporos Int (2013) 1.42
Calcium supplements in people with osteoporosis. BMJ (2010) 1.39
Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials. Am J Cardiovasc Drugs (2012) 1.30
Should we prescribe calcium supplements for osteoporosis prevention? J Bone Metab (2014) 1.24
Association between atherosclerosis and osteoporosis, the role of vitamin D. Arch Med Sci (2011) 1.15
Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001-2006). PLoS One (2010) 1.14
Divergent effects of obesity on fragility fractures. Clin Interv Aging (2014) 1.14
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. Circulation (2016) 1.13
Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol (2013) 1.10
Are more trials of calcium supplements really needed? Osteoporos Int (2017) 1.08
Meeting and exceeding dairy recommendations: effects of dairy consumption on nutrient intakes and risk of chronic disease. Nutr Rev (2013) 1.07
Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int (2012) 1.05
Osteoporosis--a risk factor for cardiovascular disease? Nat Rev Rheumatol (2012) 1.05
Recommended intakes of vitamin D to optimise health, associated circulating 25-hydroxyvitamin D concentrations, and dosing regimens to treat deficiency: workshop report and overview of current literature. J Nutr Sci (2015) 1.02
Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne) (2012) 1.01
Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum (2013) 1.01
Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2014) 1.00
Vitamin D intake and risk of cardiovascular disease in US men and women. Am J Clin Nutr (2011) 1.00
Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab (2013) 0.99
Current and future treatment options in osteoporosis. Eur J Clin Pharmacol (2011) 0.98
A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. J Bone Miner Res (2014) 0.98
Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol (2015) 0.98
Calcium intake is not associated with increased coronary artery calcification: the Framingham Study. Am J Clin Nutr (2012) 0.96
Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur J Epidemiol (2012) 0.96
Association between myocardial infarction and fractures: an emerging phenomenon. Circulation (2011) 0.96
Effects of high and low fat dairy food on cardio-metabolic risk factors: a meta-analysis of randomized studies. PLoS One (2013) 0.95
A review of calcium supplements and cardiovascular disease risk. Adv Nutr (2012) 0.94
Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One (2013) 0.94
Vitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studies. Curr Atheroscler Rep (2013) 0.93
Vitamin D and the cardiovascular system. Osteoporos Int (2013) 0.92
Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. Osteoporos Int (2012) 0.91
The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective. Climacteric (2012) 0.91
Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial. Osteoporos Int (2011) 0.91
Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review. Oncologist (2012) 0.91
Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int (2014) 0.90
Re: The calcium scare: what would Austin Bradford Hill have thought? Osteoporos Int (2011) 0.89
Integrating systems biology sources illuminates drug action. Clin Pharmacol Ther (2014) 0.88
Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep (2015) 0.88
Optimal use of vitamin D when treating osteoporosis. Curr Osteoporos Rep (2011) 0.88
Bone Health in Athletes: The Role of Exercise, Nutrition, and Hormones. Sports Health (2016) 0.88
Calcium intake in health maintenance - a systematic review. Food Nutr Res (2013) 0.87
Modifying effect of calcium/magnesium intake ratio and mortality: a population-based cohort study. BMJ Open (2013) 0.87
Management of osteoporosis of the oldest old. Osteoporos Int (2014) 0.87
Cardiovascular effects of calcium supplements. Nutrients (2013) 0.86
Prevention of fractures in older people with calcium and vitamin D. Nutrients (2010) 0.86
Calcium and Vitamin D Supplementations: 2015 Position Statement of the Korean Society for Bone and Mineral Research. J Bone Metab (2015) 0.86
Calcium-alkali syndrome in the modern era. Nutrients (2013) 0.85
Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One (2014) 0.85
Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study. Eur J Epidemiol (2013) 0.85
Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc (2016) 0.84
Bone and the perimenopause. Obstet Gynecol Clin North Am (2011) 0.84
Fracture prevention in postmenopausal women. BMJ Clin Evid (2011) 0.84
Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective. Ther Adv Chronic Dis (2012) 0.84
Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy. Crit Rev Oncol Hematol (2013) 0.84
A multimineral natural product from red marine algae reduces colon polyp formation in C57BL/6 mice. Nutr Cancer (2012) 0.83
Risk communication methods in hip fracture prevention: a randomised trial in primary care. Br J Gen Pract (2011) 0.83
Subgroup analysis for the risk of cardiovascular disease with calcium supplements. Bonekey Rep (2013) 0.83
Effect of osteoporosis medications on fracture healing. Osteoporos Int (2015) 0.83
Effects of Dairy Products Consumption on Health: Benefits and Beliefs-A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases. Calcif Tissue Int (2015) 0.82
Risk of high dietary calcium for arterial calcification in older adults. Nutrients (2013) 0.82
Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. PLoS One (2014) 0.82
Dietary calcium intake and mortality risk from cardiovascular disease and all causes: a meta-analysis of prospective cohort studies. BMC Med (2014) 0.82
Food Fortification and Supplement Use-Are There Health Implications? Crit Rev Food Sci Nutr (2016) 0.82
Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial. BMJ Open (2013) 0.81
Risk factors: Calcium supplements and cardiovascular risk. Nat Rev Cardiol (2012) 0.81
Does calcium intake affect cardiovascular risk factors and/or events? Clinics (Sao Paulo) (2012) 0.81
Fracture prevention in COPD patients; a clinical 5-step approach. Respir Res (2015) 0.80
Determinants of vitamin D supplementation prescription in nursing homes: a survey among general practitioners. Osteoporos Int (2016) 0.80
Calcium and vitamin D supplementation through fortified dairy products counterbalances seasonal variations of bone metabolism indices: the Postmenopausal Health Study. Eur J Nutr (2010) 0.80
Recent advances in the pathogenesis and treatment of osteoporosis. Clin Med (2015) 0.80
A prospective cohort study examining the associations of dietary calcium intake with all-cause and cardiovascular mortality in older Chinese community-dwelling people. PLoS One (2013) 0.80
Calcium supplements and cardiovascular risk: 5 years on. Ther Adv Drug Saf (2013) 0.80
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet (2007) 9.61
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr (2007) 9.61
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med (2000) 8.47
Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med (2007) 7.87
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int (2007) 6.34
Osteoporosis. Lancet (2006) 5.40
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ (2008) 5.14
Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med (1999) 4.11
Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med (2006) 4.09
The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens (1999) 3.72
Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med (2004) 3.64
Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) (2009) 3.51
Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med (1993) 3.31
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr (2007) 3.14
Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med (2002) 2.86
Effect of calcium supplementation on hip fractures. Osteoporos Int (2008) 2.79
Randomized controlled trial of calcium in healthy older women. Am J Med (2006) 2.78
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract (2004) 2.69
A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med (1990) 2.67
Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ (2010) 2.67
Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med (1995) 2.59
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev (2009) 2.58
Ischaemic-heart-disease mortality and dietary intake of calcium. Lancet (1973) 2.46
Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke (1999) 2.41
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int (2007) 2.40
Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol (1999) 2.36
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2008) 2.35
Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med (2008) 2.10
Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab (2000) 2.09
Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation (1998) 1.94
Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res (1998) 1.93
Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial. J Clin Endocrinol Metab (2005) 1.91
Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol (1997) 1.83
A skeleton in the atherosclerosis closet. Circulation (1995) 1.69
Clinical presentation of primary hyperparathyroidism in Europe--nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res (2002) 1.59
Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr (2006) 1.57
A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. Am J Clin Nutr (2003) 1.52
Calcium intake and 28-year cardiovascular and coronary heart disease mortality in Dutch civil servants. Int J Epidemiol (1992) 1.49
Serum calcium and cardiovascular risk factors and diseases: the Tromsø study. Hypertension (1999) 1.49
Does calcium supplementation increase cardiovascular risk? Clin Endocrinol (Oxf) (2010) 1.44
Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res (1996) 1.43
The acute biochemical effects of four proprietary calcium preparations. Aust N Z J Med (1986) 1.42
Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg (2003) 1.40
Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density. Curr Med Res Opin (2007) 1.39
Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas (2009) 1.34
Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev (2008) 1.26
Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab (1991) 1.18
Calcium supplementation and bone loss in middle-aged women. Am J Clin Nutr (1989) 1.10
Postprandial metabolic responses to milk enriched with milk calcium are different from responses to milk enriched with calcium carbonate. Asia Pac J Clin Nutr (2003) 1.05
Calcium supplementation: Results may not be generalisable. BMJ (2008) 1.01
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med (2005) 15.46
Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med (2009) 13.57
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med (2003) 6.99
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ (2008) 5.14
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol (2009) 5.05
Paget's disease of bone: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 4.63
Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am (2004) 4.42
Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am (2003) 4.38
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab (2007) 4.01
Meta-analysis: protein and energy supplementation in older people. Ann Intern Med (2006) 3.73
Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet (2007) 3.66
Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA (2007) 3.44
Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst (2003) 3.44
Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am (2003) 3.33
Constipation and a low-fiber diet are not associated with diverticulosis. Clin Gastroenterol Hepatol (2013) 3.31
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst (2009) 3.15
Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr (2007) 3.14
Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 3.11
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst (2013) 3.06
Association of hospital and surgeon volume of total hip replacement with functional status and satisfaction three years following surgery. Arthritis Rheum (2003) 2.98
Identification of Lynch syndrome among patients with colorectal cancer. JAMA (2012) 2.77
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial. J Am Dent Assoc (2008) 2.75
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol (2003) 2.72
One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med (2012) 2.70
Factors influencing mortality in acromegaly. J Clin Endocrinol Metab (2004) 2.69
Sample size calculator for cluster randomized trials. Comput Biol Med (2004) 2.68
Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am (2005) 2.67
Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst (2009) 2.64
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst (2009) 2.56
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol (2010) 2.50
Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut (2013) 2.50
Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol (2013) 2.46
Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr (2011) 2.44
Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology (2007) 2.39
Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet (2013) 2.37
Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet (2011) 2.34
Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut (2010) 2.30
Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med (2002) 2.24
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol (2012) 2.22
Vitamin D: a place in the sun? Arch Intern Med (2010) 2.18
Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.17
Interventions to achieve long-term weight loss in obese older people: a systematic review and meta-analysis. Age Ageing (2010) 2.16
Telomere length varies by DNA extraction method: implications for epidemiologic research. Cancer Epidemiol Biomarkers Prev (2013) 2.14
Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening. Cancer Epidemiol Biomarkers Prev (2008) 2.12
Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst (2008) 2.11
Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med (2008) 2.10
Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med (2004) 2.07
Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect. J Bone Miner Res (2011) 2.07
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res (2008) 2.04
Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review. Am J Prev Med (2005) 2.04
Discrepancies in predicted fracture risk in elderly people. BMJ (2013) 2.04
Development of common data elements: the experience of and recommendations from the early detection research network. Int J Med Inform (2003) 2.04
Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila) (2011) 2.03
Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res (2007) 2.02
Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst (2010) 1.99
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 1.98
Survival after hip fracture. Osteoporos Int (2005) 1.93
Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2004) 1.93
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res (2012) 1.92
Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev (2009) 1.88
Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review. Clin Endocrinol (Oxf) (2008) 1.85
The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am J Clin Nutr (2007) 1.83
Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension (2005) 1.82
Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev (2009) 1.80
Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation (2004) 1.80
Association of hospital and surgeon procedure volume with patient-centered outcomes of total knee replacement in a population-based cohort of patients age 65 years and older. Arthritis Rheum (2007) 1.78
Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA (2008) 1.73
Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial. J Natl Cancer Inst (2007) 1.73
Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone. J Bone Miner Res (2010) 1.73
Associations between smoking, alcohol consumption, and colorectal cancer, overall and by tumor microsatellite instability status. Cancer Epidemiol Biomarkers Prev (2009) 1.72
Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol (2013) 1.71
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut (2011) 1.70
Does enteral nutrition affect clinical outcome? A systematic review of the randomized trials. Am J Gastroenterol (2007) 1.70
Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study. Med J Aust (2013) 1.69
Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab (2010) 1.68
Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst (2004) 1.67
Twelve-year risk of revision after primary total hip replacement in the U.S. Medicare population. J Bone Joint Surg Am (2012) 1.67
Colon and rectal cancer survival by tumor location and microsatellite instability: the Colon Cancer Family Registry. Dis Colon Rectum (2013) 1.65
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) (2012) 1.65
Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet (2012) 1.64
Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr (2010) 1.64